| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |